| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/31/2007 | WO2007060626A1 Novel thiophene derivatives |
| 05/31/2007 | WO2007060618A2 Macrolides derivatives as antibacterial agents |
| 05/31/2007 | WO2007060540A1 Stable dosage forms of an antidepressant |
| 05/31/2007 | WO2007060526A1 Substituted azacycloalkanes useful for treating cns conditions |
| 05/31/2007 | WO2007060512A2 Compositions containing topical active agents and pentylene glycol |
| 05/31/2007 | WO2007060484A1 Azetidine derivatives as glyt1 inhibitors |
| 05/31/2007 | WO2007060458A2 Treatment of ophthalmic diseases with beta-amino alcohols |
| 05/31/2007 | WO2007060453A1 Promoting wound healing by administering a prostaglandin e and granulocyte-macrophage colony stimulating factor |
| 05/31/2007 | WO2007060419A2 Method of preventing oral staining |
| 05/31/2007 | WO2007060413A1 Treatment of sub-gingival pocket infections |
| 05/31/2007 | WO2007060409A1 L-alanine derivatives |
| 05/31/2007 | WO2007060404A1 PYRIDO-,PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS |
| 05/31/2007 | WO2007060402A1 Pharmaceutical compositions |
| 05/31/2007 | WO2007060318A1 Novel indolizine derivatives, method for preparing same and therapeutic compositions comprising same |
| 05/31/2007 | WO2007060302A1 Use of a composition containing an ecdysteroid |
| 05/31/2007 | WO2007060253A1 Substituted aminophenylsulfonamide compounds as hiv protease inhibitor |
| 05/31/2007 | WO2007060249A1 Aminophenylsulfonamide derivatives as hiv protease inhibitor |
| 05/31/2007 | WO2007060208A2 Fast-dissolving isotropic expanded microporous composition or structure for pharmaceutical, veterinary, dietetic, food or cosmetic use and method for obtaining same |
| 05/31/2007 | WO2007060206A2 Further crystalline forms of rostafuroxin |
| 05/31/2007 | WO2007060198A1 Pyrazoloisoquinoline derivatives |
| 05/31/2007 | WO2007060182A1 Use of n-(2-((3-(4-bromophenyl)-2-propenyl)amino)ethyl)-5-isoquinolinesulfonamide (h89) in a depigmenting pharmaceutical composition |
| 05/31/2007 | WO2007060132A1 N-hydroxyamide derivatives and use thereof |
| 05/31/2007 | WO2007060121A1 Indanyl-and tetrahydronaphthyl-amino-azoline compounds for combating animal pests |
| 05/31/2007 | WO2007060112A1 Salicylic acid derivatives |
| 05/31/2007 | WO2007060110A1 4-aminopyrimidine-5-thione-derivatives for the treatment of cancer |
| 05/31/2007 | WO2007060108A2 Aerosol formulation for inhalation containing an anticholinergic agent |
| 05/31/2007 | WO2007060107A1 Aerosol formulation for inhalation containing an anticholinergic agent |
| 05/31/2007 | WO2007060106A1 Aerosol formulation for inhalation containing an anticholinergic agent |
| 05/31/2007 | WO2007060105A1 Aerosol formulation for inhalation containing an anticholinergic agent |
| 05/31/2007 | WO2007060104A2 Aerosol formulation for inhalation containing an anticholinergic agent |
| 05/31/2007 | WO2007060038A2 Preparation, comprising iron(iii) complex compounds and redox-active substances |
| 05/31/2007 | WO2007060028A1 Napthyridine compounds as rock inhibitors |
| 05/31/2007 | WO2007060027A1 Isoquinoline et benzo[h]isoquinoline derivatives, preparation and therapeutic use thereof as antagonists of histamine h3 receptor |
| 05/31/2007 | WO2007060026A1 Urea derivatives useful as calcium receptor modulators |
| 05/31/2007 | WO2007060011A1 Therapy of malignant neoplasias |
| 05/31/2007 | WO2007059963A1 F,g,h,i and k crystal forms of imatinib mesylate |
| 05/31/2007 | WO2007059960A1 Use of 25-hydroxy vitamin d3 to improve vitality of animals |
| 05/31/2007 | WO2007059953A1 Formulation comprising a polyphenol-containing composition and isomaltulose |
| 05/31/2007 | WO2007059949A1 Two novel salts of the n, n' -bis [9- (3,4-dihydroxy-5- (2-ethyl-2h-tetrazol-5-yl) tetrahydrofuran-2-yl) -2- (2- (1-methyl-1h-imidazol-4-yl) ethylamino) -9h-purin-6-yl] cyclohexyl-1,4-diamine adenosine a2a agonist as anti-inflammatory agents |
| 05/31/2007 | WO2007059918A1 Use of a combination of ethynylestradiol and chlormadinone acetate for the treatment of mood changes |
| 05/31/2007 | WO2007059905A2 Thienopyrimidines treating inflammatory diseases |
| 05/31/2007 | WO2007059872A1 Pyridylsulfonamide derivatives, their manufacture and use as antineoplastic agents |
| 05/31/2007 | WO2007059871A1 Hydroxy-substituted diphenylazetidinones for the treatment of hyperlipidaemia |
| 05/31/2007 | WO2007059762A1 Combination preparations containing physiological cell membrane constituents including phosphatidylserine, choline and a pyrimidine nucleoside/nucleotide |
| 05/31/2007 | WO2007059685A1 Astragalus calycosin with the function of resisting coxackievirus |
| 05/31/2007 | WO2007059631A1 Selected dosage for the treatment of cardiovascular and related pathologies |
| 05/31/2007 | WO2007059620A1 Method for administering formoterol using a nebulizer |
| 05/31/2007 | WO2007059613A1 Antineoplastic compounds |
| 05/31/2007 | WO2007059611A1 2-(phenyl or heterocyclic)-1h-phenantrho[9,10-d]imidazoles as mpges-1 inhibitors |
| 05/31/2007 | WO2007059610A1 2-(phenyl or heterocyclic)-1h-phenantrho[9,10-d]imidazoles as mpges-1 inhibitors |
| 05/31/2007 | WO2007059608A1 Compositions and methods for modulating gated ion channels |
| 05/31/2007 | WO2007059605A1 Composition and method for efficient delivery of nucleic acids to cells using chitosan |
| 05/31/2007 | WO2007059584A1 Methods for wound healing |
| 05/31/2007 | WO2007048059A3 Method of treating clostridium difficile-associated diarrhea |
| 05/31/2007 | WO2007044973A3 Acyclic n-halamines in antibacterial materials |
| 05/31/2007 | WO2007044574A3 Pharmaceutical compositions, methods of preparation thereof, and methods of treatment |
| 05/31/2007 | WO2007044015A9 Treating or preventing renal cancer using a dimethane sulfonate |
| 05/31/2007 | WO2007042669A3 Derivatives of 4-amino-quinazoline, preparation method thereof and use of same in therapeutics |
| 05/31/2007 | WO2007042660A3 Substituted 1-amino-phthalzine derivatives, preparation and therapeutic use thereof |
| 05/31/2007 | WO2007041077A3 Heterocyclic amide derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 05/31/2007 | WO2007041061A3 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 05/31/2007 | WO2007041052A3 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
| 05/31/2007 | WO2007040438A3 Novel imidazo [4,5 -b] pyridine derivatives as inhibitors of glycogen synthase kinase 3 for use in the treatment of dementia and neurodegenerative disorders |
| 05/31/2007 | WO2007039740A3 Preparation and use of tetrahydropyrrolo [3, 2-c] pyridin-4-one derivatives for treatment of obesity, psychiatric and neurological disorders |
| 05/31/2007 | WO2007038677A3 Methods for preparation of ladostigil tartrate crystalline form a1 |
| 05/31/2007 | WO2007037560A9 Therapeutic or diagnostic application of sgk2 gene |
| 05/31/2007 | WO2007037555A9 Therapeutic or diagnostic application of dusp15 gene |
| 05/31/2007 | WO2007037554A9 Adsorbent for advanced glycation endproducts |
| 05/31/2007 | WO2007037550A9 Therapeutic or diagnostic application of tsta3 gene |
| 05/31/2007 | WO2007037543A9 Biarylamide derivative |
| 05/31/2007 | WO2007037538A9 Therapeutic or diagnostic application of spo11 gene |
| 05/31/2007 | WO2007037534A9 2-heteroaryl-substituted indole derivative |
| 05/31/2007 | WO2007037533A9 Therapeutic or diagnostic application of ppp1r3d gene |
| 05/31/2007 | WO2007037532A9 Therapeutic or diagnostic application of srms gene |
| 05/31/2007 | WO2007037518A9 Mutilin derivative and pharmaceutical composition containing the same |
| 05/31/2007 | WO2007036771A3 Pantoprazole free acid form iii |
| 05/31/2007 | WO2007036718A3 Compounds which have activity at m1 receptor and their uses in medicine |
| 05/31/2007 | WO2007035348A3 Nanoparticulate aripiprazole formulations |
| 05/31/2007 | WO2007034477A3 Modulation of osteoclast differentiation |
| 05/31/2007 | WO2007031785A3 Bisphosphonate formulation |
| 05/31/2007 | WO2007031520A3 Use of octenidine dihydrochloride in semisolid preparations |
| 05/31/2007 | WO2007031519A3 Antimicrobial preparations having a content of octenidine dihydrochloride encapsulated in liposomes |
| 05/31/2007 | WO2007030721A3 Processes for the preparation of (3r,4s)-4-((4-benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((s)-3-(4-fluorophenyl)-3-hydroxypropyl)-2-azetidinone, an intermediate for the synthesis of ezetimibe |
| 05/31/2007 | WO2007030618A3 Bicyclic derivatives as modulators of voltage gated ion channels |
| 05/31/2007 | WO2007030438A3 Aminopurine derivatives for treating neurodegenerative diseases |
| 05/31/2007 | WO2007030361A3 Benzimidazole thiophene compounds as plk inhibitors |
| 05/31/2007 | WO2007030360A3 P13k inhibitors for the treatment of endometriosis |
| 05/31/2007 | WO2007030117A3 Multifunctional self-decontaminating surface coating |
| 05/31/2007 | WO2007030089A8 Tricyclic delta- opioid modulators |
| 05/31/2007 | WO2007029268A3 Stable oxaliplatin formulation |
| 05/31/2007 | WO2007028524A3 Use of a derivative of imidazole for the treatment of leukotriene related disorders |
| 05/31/2007 | WO2007028020A3 Liposome compositions |
| 05/31/2007 | WO2007027894A3 Antisense compounds having enhanced anti-microrna activity |
| 05/31/2007 | WO2007027651A3 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| 05/31/2007 | WO2007027323A3 TRICYCLIC 6-ALKYLIDENE-PENEM β-LACTAMASE INHIBITORS AND β-LACTAM ANTIBIOTIC COMBINATION: A BROAD SPECTRUM ANTIBIOTIC |
| 05/31/2007 | WO2007026251A8 Use of dual c-kit/fgfr3 inhibitors for treating multiple myeloma |
| 05/31/2007 | WO2007025763A3 Highly cross-linked reagents for modifying biopharmaceuticals, production and use thereof |
| 05/31/2007 | WO2007024863A2 Methods and formulations for modulating lyn kinase activity and treating related disorders |
| 05/31/2007 | WO2007024767A3 Pheromone compositions and methods |
| 05/31/2007 | WO2007024294A3 Certain substituted ureas, as modulators of kinase activity |